The CCR5 antagonist maraviroc exerts limited neuroprotection without improving neurofunctional outcome in experimental pneumococcal meningitis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The CCR5 antagonist maraviroc exerts limited neuroprotection without improving neurofunctional outcome in experimental pneumococcal meningitis ; volume:12 ; number:1 ; day:28 ; month:7 ; year:2022 ; pages:1-12 ; date:12.2022
Scientific reports ; 12, Heft 1 (28.7.2022), 1-12, 12.2022
- Urheber
-
Le, Ngoc Dung
Steinfort, Marel
Grandgirard, Denis
Maleska, Aleksandra
Leppert, David
Kuhle, Jens
Leib, Stephen L.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-17282-0
- URN
-
urn:nbn:de:101:1-2022102312264889704399
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Le, Ngoc Dung
- Steinfort, Marel
- Grandgirard, Denis
- Maleska, Aleksandra
- Leppert, David
- Kuhle, Jens
- Leib, Stephen L.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection
CCR5 Antagonist and Agonist Binding Site Structures
DHCR24 exerts neuroprotection upon inflammation-induced neuronal death
CCR5 and CXCR4 antagonist and agonist binding sites
Metformin mediates neuroprotection and attenuates hearing loss in experimental pneumococcal meningitis
Icariin attenuates neuroinflammation and exerts dopamine neuroprotection via an Nrf2-dependent manner
Postconditioning with D-limonene exerts neuroprotection in rats via enhancing mitochondrial activity
The CCR5 chemokine receptor antagonist maraviroc exerts anti-neoplastic activity in pancreatic cancer cells, which may be a novel strategy for treating metastatic pancreatic cancer
Changes in CCR5+ cells and antigen-specific CD4+ T-cells during monotherapy with a CCR5 antagonist SCH532706 compared with combination therapy
FGF-2 released from degenerating neurons exerts microglial-induced neuroprotection via FGFR3-ERK signaling pathway
A CCR5 antagonist, maraviroc, alleviates neural circuit dysfunction and behavioral disorders induced by prenatal valproate exposure
CNS neuroprotection
Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection
CCR5 Antagonist and Agonist Binding Site Structures
DHCR24 exerts neuroprotection upon inflammation-induced neuronal death
CCR5 and CXCR4 antagonist and agonist binding sites
Metformin mediates neuroprotection and attenuates hearing loss in experimental pneumococcal meningitis
Icariin attenuates neuroinflammation and exerts dopamine neuroprotection via an Nrf2-dependent manner
Postconditioning with D-limonene exerts neuroprotection in rats via enhancing mitochondrial activity
The CCR5 chemokine receptor antagonist maraviroc exerts anti-neoplastic activity in pancreatic cancer cells, which may be a novel strategy for treating metastatic pancreatic cancer
Changes in CCR5+ cells and antigen-specific CD4+ T-cells during monotherapy with a CCR5 antagonist SCH532706 compared with combination therapy
FGF-2 released from degenerating neurons exerts microglial-induced neuroprotection via FGFR3-ERK signaling pathway
A CCR5 antagonist, maraviroc, alleviates neural circuit dysfunction and behavioral disorders induced by prenatal valproate exposure
CNS neuroprotection
Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection
CCR5 Antagonist and Agonist Binding Site Structures
DHCR24 exerts neuroprotection upon inflammation-induced neuronal death
CCR5 and CXCR4 antagonist and agonist binding sites
Metformin mediates neuroprotection and attenuates hearing loss in experimental pneumococcal meningitis
Icariin attenuates neuroinflammation and exerts dopamine neuroprotection via an Nrf2-dependent manner
Postconditioning with D-limonene exerts neuroprotection in rats via enhancing mitochondrial activity
The CCR5 chemokine receptor antagonist maraviroc exerts anti-neoplastic activity in pancreatic cancer cells, which may be a novel strategy for treating metastatic pancreatic cancer
Changes in CCR5+ cells and antigen-specific CD4+ T-cells during monotherapy with a CCR5 antagonist SCH532706 compared with combination therapy
FGF-2 released from degenerating neurons exerts microglial-induced neuroprotection via FGFR3-ERK signaling pathway
A CCR5 antagonist, maraviroc, alleviates neural circuit dysfunction and behavioral disorders induced by prenatal valproate exposure